In an aggressive mouse model of AD (i.e., 5xFAD mice), ΔCN was similarly observed in activated astrocytes in the hippocampus, increasing in direct proportion to elevated GFAP levels (Sompol et al., 2017). The gene discussed is GFAP; the disease is Alzheimer disease.